| COLLPLANT BIOTECHNOLOGIES |
| Israel |
| Gesundheit |
| IL0004960188 / A1CY27 |
| CPT (Frankfurt) / CLGN (NASDAQ) |
| FRA:CPT, ETR:CPT, CPT:GR, NASDAQ:CLGN |
| - |
| https://collplant.com/ |
|
CollPlant Biotechnologies Ltd. is a pioneering biomedical company that specializes in regenerative medicine and tissue engineering. At the heart of its offerings is the development of innovative human tissue products using plant-based recombinant col..
>Volltext.. |
| 6.6 Mio. EUR |
| 3.91 Mio. EUR |
| 2.05 Mio. EUR |
| -9.16 Mio. EUR |
| -9.95 Mio. EUR |
| -0.81 EUR |
| 2.47 Mio. EUR |
| 5.15 Mio. EUR |
| -8.65 Mio. EUR |
| 2.23 |
| 360.39% |
| 30.83% |
| - |
| - |
| - |
| - |
| COLLPLANT |
| 05.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|